← Back to Clinical Trials
Recruiting NCT06214039

NCT06214039 Virtual Reality Exposure for Public Speaking Anxiety

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06214039
Status Recruiting
Phase
Sponsor Vilnius University
Condition Public Speaking Anxiety
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2024-02-14
Primary Completion 2025-05

Trial Parameters

Condition Public Speaking Anxiety
Sponsor Vilnius University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 80
Sex ALL
Min Age 18 Years
Max Age 30 Years
Start Date 2024-02-14
Completion 2025-05
Interventions
Exposure in virtual reality and text based cognitive behavioral therapy (CBT) for public speaking anxiety

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study aims to examine the efficacy of exposure using virtual reality (VR) for public speaking anxiety in young adults in two treatment arms: a one-session VR exposure therapy with a 4-week online transition intervention versus a three-session VR exposure therapy with a 4-week online transition intervention. Previous studies have demonstrated that one-session therapy (OST) is comparable to prolonged exposure-based therapies in terms of effectively reducing public speaking anxiety. Moreover, VR offers many benefits compared to in-person exposure, namely the ability to produce anxiety-evoking stimuli without having to leave the therapist's room. However, OST VR exposure has not been directly compared to prolonged VR exposure and not for public speaking anxiety.

Eligibility Criteria

Inclusion Criteria: * aged 18-30 and studying in higher education; * experiencing a significant level of public speaking anxiety (60+ on PSAS); * able to use a computer and have access to the internet for the duration of the study; * able to understand, write and speak in Lithuanian; * available to participate in one or three in-person intervention sessions and can devote the time to participate in a 4-week online program following the intervention sessions. Exclusion Criteria: * a history of seizures or a history of epilepsy; * other significant medical conditions that would prevent them from participating in the program; * high levels of depression (Patient Health Questionnaire-9 rating of 15 and above and mentions of suicidal ideation) or other significant psychiatric conditions that would interfere with participation in the program; * a tendency to have extreme seasickness reactions or a history of adverse physical reactions to virtual reality experiences or difficulty with or lack

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology